Skip to main content

Security report for zentiva.rs

Zentiva Pharma d.o.o. · Healthcare · Serbia

Low risk. 3 critical or high findings in Email security, Security headers and 1 other check.

Security score

77/100

Risk levelLow

0–100, higher is better. How it is calculated

Zentiva Pharma d.o.o. is a well-established pharmaceutical company operating primarily in Serbia with multiple subsidiaries and offices across Europe and India. The company focuses on manufacturing and distributing pharmaceutical products, targeting healthcare professionals and patients. The website reflects a professional corporate presence with consistent branding and detailed contact information for various country offices. Technically, the site employs modern web technologies including Google Tag Manager and Cookiebot for consent management, ensuring compliance with privacy regulations. Security posture is solid with HTTPS enabled and CSRF protections in place, though there is room for improvement in security headers and incident response transparency. Overall, the site is trustworthy and aligns well with the business's market position and history.

Scanned

NIS2 and GDPR posture

GDPR outside view
100/ 100 · Low
Checks completed
7of 7

NIS2 Art. 21(2)

  1. (a) Risk analysis and security policies: Not visible from outside
  2. (b) Incident handling: One indicator
  3. (c) Business continuity, backups and crisis management: Not visible from outside
  4. (d) Supply chain security: Not visible from outside
  5. (e) Secure acquisition, development and maintenance, including vulnerability handling: Partly checked
  6. (f) Assessing the effectiveness of security measures: Not visible from outside
  7. (g) Cyber hygiene and security training: Not visible from outside
  8. (h) Cryptography and encryption: Partly checked
  9. (i) HR security, access control and asset management: One indicator
  10. (j) Multi-factor authentication and secured communications: Not visible from outside

This scan rated NIS2 with an earlier keyword method that is no longer shown; rescan for the per-article view. Risk management, continuity, supply chain, training, MFA, management oversight (Art. 20) and incident reporting (Art. 23) need internal evidence, and Guard cannot tell whether NIS2 applies to this organisation.

GDPR is indicative only, based on publicly visible signals: Articles 7, 12, 13 and 32 of Regulation (EU) 2016/679 and Article 5(3) of the ePrivacy Directive. Not a certification or legal assessment.

Priority findings

3 findings rated critical or high. Fix these first.

  1. Email security

    SPF, DKIM and DMARC stop others sending email that looks like it comes from your domain, a common route to phishing and invoice fraud.

    • Critical

      No email authentication configured

      Domain is vulnerable to email spoofing

      What to do: Implement SPF, DKIM, and DMARC immediately

  2. Security headers

    Security headers are instructions your web server sends to every visitor’s browser. Missing ones leave visitors more exposed to attacks such as clickjacking and injected scripts.

    • High

      Missing Content-Security-Policy header

      Controls resources the browser is allowed to load

      What to do: Implement a Content-Security-Policy appropriate for your application

      • ASVS V3.4.3
      • OWASP Secure Headers: OWASP Secure Headers Project recommends Content-Security-Policy: default-src 'self'; form-action 'self'; base-uri 'self'; object-src 'none';…
  3. SSL/TLS

    TLS encrypts the connection and proves the site is really yours. Weak or expiring certificates trigger browser warnings and put traffic at risk.

    • High

      Weak Protocols Supported

      Server supports weak protocols: TLSv1.1

      What to do: Disable TLS 1.0, TLS 1.1, and all SSL versions

      • CWE-327
      • OWASP A04:2025
      • ASVS V12.1.1

Need hands-on remediation? Email guard@offseq.com

Keep watching zentiva.rs

This scan found 18 issues across 5 checks. Monitoring re-runs those checks daily, emails you when something material changes and records each fix, so you can show progress.

Daily monitoring

Recommended

€25per month

  • TLS certificates and expiry
  • DNS records
  • SPF, DKIM and DMARC
  • Security headers
  • GDPR and NIS2 posture
  • Exposed services
  • Third-party trackers
  • Security score drift

Email alerts on material changes and an exportable JSON history of every change.

Billed monthly to your card. Cancel anytime. See sample alerts.

Full report

€39.90one-time

  • The complete analysis as a PDF you can cite
  • Email delivery with an unlock code
  • Lifetime access to this report

Prices incl. 21% VAT. Secure checkout by Mollie; sold by SEQ SIA, Latvia.

Results by check

Each check with its score, findings and the evidence it collected.

How this score is calculated

The security score runs 0–100, higher is better. It is the plain average of the security checks that completed in this scan, each counted equally. A check that could not run is left out: it counts neither as a pass nor as a fail.

Counted in this score

SSL/TLS
72
Security headers
70
Email security
60
DNS health
60
Network security
100
GDPR outside view
100
Average
77

Not counted

  • NIS2 outside view: Re-weights evidence from the TLS, email, DNS, network and hygiene checks, so counting it would count that evidence twice. Shown on its own.
  • OffSeq Observations: An AI reading of the site, useful context but not reproducible evidence. Shown on its own.

Findings that cap the score at 49

Each of these is serious on its own, so while any is present the site cannot rate better than high risk, however good the other checks are.

  • The certificate is not trusted by browsers
  • The website is not served over HTTPS
  • A database, remote desktop, file-sharing or Telnet service is reachable from the internet
  • The page loads a script from a compromised source
  • The domain registration has expired
  • SPF authorises every server to send mail as the domain

Partial scans

When the site blocks Guard or most checks cannot run, the score covers only the checks that ran (usually DNS and email), is capped at 75 and is shown as partial, without a risk level.

Risk levels

  • Critical0–25
  • High26–49
  • Medium50–75
  • Low76–100

Technical appendix

Business context, site observations and technical notes gathered during the scan, and the standards behind each reference.

Business context

Business profile

Zentiva holds a strong market position as a regional pharmaceutical manufacturer and distributor, supported by a parent company and multiple subsidiaries. The business model centers on healthcare product provision with a focus on compliance and customer engagement. The presence of multiple country-specific domains and contact points indicates a broad operational footprint. The company leverages partnerships and maintains a transparent contact ecosystem, which supports growth and customer trust. The website content and structure support professional communication with stakeholders and customers, reflecting a mature business intelligence approach.

Security posture

The website demonstrates a moderate to good security maturity level, with HTTPS enforced and anti-CSRF tokens implemented. Cookie consent is managed via Cookiebot, indicating GDPR awareness. However, the absence of advanced security headers such as Content Security Policy (CSP), HTTP Strict Transport Security (HSTS), and X-Frame-Options suggests potential areas for enhancement. No vulnerability disclosures or incident response contacts are published, which could impact incident handling readiness. Overall, the security posture is adequate for a corporate site but would benefit from additional hardening and transparency measures.

Recommendations

  1. Enable DNSSEC to improve domain name system security.
  2. Implement comprehensive security headers including CSP, HSTS, and X-Frame-Options.
  3. Publish a dedicated security policy and incident response contact information.
  4. Add a vulnerability disclosure program or security.txt file to facilitate responsible reporting.
  5. Enhance privacy policy visibility and ensure it comprehensively covers GDPR requirements.

Contact details published on the site

Addresses
Legal name
Zentiva Pharma d.o.o.
Site observations

Automated reading of the public site. Ratings are indicative.

Business

Company
Zentiva Pharma d.o.o.
Description
Zentiva is a pharmaceutical company providing medicines and healthcare products, targeting healthcare professionals and patients in Serbia and other countries.
Key services
Pharmaceutical production, Healthcare product distribution, Customer support
Content quality
good
Branding
consistent

Technology

Stack
Google Tag Manager, Cookiebot, Modernizr, Select2, Google Fonts (Roboto)
Performance
moderate
Mobile
good
Accessibility
basic
SEO
basic

Security

Observed score
75/100
Good practices seen
  • HTTPS enabled
  • CSRF token cookie present
  • Cookie consent mechanism implemented

Analytics and tracking

Services
Google Analytics
Tracking level
moderate
Privacy practices
good

Advertising

Ad networks
Google
Tracking pixels
Cookiebot tracking
Transparency
good

Site quality

Design
good
User experience
good
Content relevance
good
Navigation
good
Professionalism
good
Trustworthiness
high

Key observations

  1. Website uses HTTPS with valid SSL.
  2. Cookie consent mechanism is implemented with detailed cookie categories.
  3. Multiple country offices and contact details provided.
  4. No explicit privacy policy page found on homepage; cookie policy is present.
  5. No terms of service or security policy pages detected.
  6. No security.txt or vulnerability disclosure found.
  7. No incident response or abuse contact emails found.
  8. Website content is professional and relevant to pharmaceutical industry.
  9. No suspicious or malicious content detected.
Technical notes

Notes

The website uses a modern tech stack with asynchronous loading of scripts such as Google Tag Manager and Cookiebot, improving performance and compliance. The use of Google Fonts and Select2 enhances UI/UX. However, no specific CMS or hosting provider is identified, suggesting a custom or proprietary platform. Performance is moderate with room for optimization. Accessibility features are basic but present, and SEO metadata is included though minimal. The site is mobile-optimized with responsive design elements. Technical risks are low but could be mitigated by improving security headers and privacy disclosures.
Standards and sources

Reference chips under each finding point to the standard, regulation or specification the finding relates to. They are taken from the official datasets below and mapped conservatively: a finding with no defensible link shows none. NIS2 and GDPR references mark where a finding is relevant evidence, not a compliance verdict. Implementing Regulation (EU) 2024/2690 binds digital infrastructure and digital service providers; for other entities it is the most detailed public reading of the Article 21 measures. WCAG, EN 301 549, European Accessibility Act and Web Accessibility Directive references name the requirement an automated accessibility rule relates to; they are not a conformance verdict.

Retrieved 2026-10-25

Reviews of this site

Share your experience with zentiva.rs. Every review is verified by email and published after moderation.

Overall rating
Select a rating
4000 characters remaining

We’ll email you to confirm your review and keep your details private.

Community rating

No published reviews yet. Be the first to review zentiva.rs.

Feedback on this report

Rate this report, add an optional comment, and tell us if you want a security specialist to follow up.

Overall report quality
Select a rating
2000 characters remaining

We only use your feedback to improve Guard reports. Contact details are never shared.